ARCHIVES

DCT Board Approves New Screening Program, Natural Product Concpets

This article is from The Cancer Letter archive.

Vol. 11 No. 09 | March 1, 1985

Download PDF Visit The Full Archive

Related Articles

Chabner Object To Yarbro’s Remarks On Federal Role In Clinical Research

April 15, 1983

NLST Shows 20.3 Percent Mortality Benefit For CT Vs. X-Ray In Lung Cancer Screening

November 5, 2010

In Brief: Cancer Panel to Meet Sept. 30 In Boston; House Passes Money Bill, With 41.347 Billion For NCI

August 15, 1986

FDA Simplifies Reporting Of Adverse Events

June 18, 1993

Reagan Family History Shows String Risk Factor

August 2, 1985

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007